Ourania Tatsis

CIK 1789815 · EVP, Chief Reg. & Quality Off. · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.92M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$20.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODTX Director $0 1 2026-05-11
VRTX EVP, Chief Reg. & Quality Off. 47,023 $444.93 $20.92M -$20.57M 48 2026-02-26
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 3 2025-07-28

Recent Filings · Page 5 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-19 VRTX Tax (F) −2,000 -$423.5K EDGAR
2021-02-12 VRTX Tax (F) −1,230 -$263.4K EDGAR
2021-02-05 VRTX Grant (A) +22,960 $0 EDGAR
2020-05-19 VRTX Sell (S) −120 -$34.1K EDGAR
2020-05-08 VRTX Mixed -$95.3K EDGAR
2020-02-26 VRTX Mixed −2,332 -$550.0K EDGAR
2020-02-19 VRTX Mixed −1,876 -$455.8K EDGAR
2020-02-07 VRTX Mixed +9,694 -$63.2K EDGAR
2020-01-10 VRTX Mixed -$67.0K EDGAR
2019-11-19 VRTX Sell (S) −5 -$1.0K EDGAR
Showing 4150 of 52
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.